| Aug 15 |
AstraZeneca (AZN) Imfinzi Combo Gets EU Nod for Uterine Cancer
|
| Aug 15 |
George Soros Amplifies S&P 500 ETF Trust Holdings in Q2 2024
|
| Aug 14 |
Federal Judge Rejects Patent Claims Supporting Puma Biotechnology's Breast Cancer Drug; Company Shares Down After Hours
|
| Aug 14 |
Health Care Roundup: Market Talk
|
| Aug 14 |
AstraZeneca's Imfinzi/Lynparza combo granted EU approval
|
| Aug 14 |
AstraZeneca’s new £450m UK vaccine hub under threat from Reeves’ state aid review
|
| Aug 14 |
Drugmaker AstraZeneca’s Market Value Soars Past £200 Billion
|
| Aug 14 |
China approves AstraZeneca-Daiichi Sankyo’s gastric cancer therapy
|
| Aug 14 |
3 UK Stocks That Are Up To 49.3% Below Intrinsic Value Estimates
|
| Aug 14 |
AstraZeneca PLC (LON:AZN) Shares Could Be 49% Below Their Intrinsic Value Estimate
|
